MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
COMPLETEDNCT00003402·PHASE2·University of Maryland, Baltimore·35 enrolled
carmustinecisplatincyclophosphamidedexamethasoneetoposide+4 more
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
COMPLETEDNCT00296023·NA·University of California, San Francisco·25 enrolled
anti-thymocyte globulinfilgrastimtherapeutic allogeneic lymphocytesbusulfanfludarabine phosphate+4 more
Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
COMPLETEDNCT00003970·PHASE1·National Cancer Institute (NCI)·60 enrolled
irinotecan hydrochloride
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
TERMINATEDNCT00004058·PHASE1·University of Medicine and Dentistry of New Jersey
tetradecanoylphorbol acetate
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
COMPLETEDNCT00004057·PHASE1·Memorial Sloan Kettering Cancer Center·40 enrolled
L-778,123paclitaxel
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00004145·PHASE2·University of Chicago·16 enrolled
anti-thymocyte globulincyclophosphamidefludarabine phosphateperipheral blood stem cell transplantation
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
COMPLETEDNCT00003816·PHASE2 / PHASE3·Roswell Park Cancer Institute·361 enrolled
anti-thymocyte globulinbusulfancarboplatincyclophosphamideetoposide+4 more
Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
COMPLETEDNCT00559104·PHASE2·City of Hope Medical Center·60 enrolled
carmustinecyclophosphamideetoposideautologous hematopoietic stem cell transplantationperipheral blood stem cell transplantation+2 more
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
COMPLETEDNCT00003883·PHASE3·Fred Hutchinson Cancer Center·578 enrolled
fluconazoleitraconazole
A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma
COMPLETEDNCT00269113·PHASE3·Hoffmann-La Roche·360 enrolled
rituximab [MabThera/Rituxan]Standard chemotherapy
Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma
COMPLETEDNCT00005580·PHASE1·Virginia Commonwealth University·54 enrolled
bryostatin 1fludarabine phosphate
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00003396·PHASE2·University of Maryland, Baltimore·42 enrolled
anti-thymocyte globulingraft-versus-tumor induction therapycyclophosphamidemelphalanperipheral blood stem cell transplantation+1 more
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00003398·PHASE4·University of Maryland, Baltimore·45 enrolled
anti-thymocyte globulinfilgrastimcyclophosphamidethiotepaallogeneic bone marrow transplantation+2 more
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00003397·PHASE2·University of Maryland, Baltimore·25 enrolled
filgrastimrituximabsargramostimcarmustinecisplatin+8 more
Combination Chemotherapy in Treating Patients With Advanced Cancer
COMPLETEDNCT00004105·PHASE1 / PHASE2·NYU Langone Health
estramustine phosphate sodiumpaclitaxelvinorelbine ditartrate
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
COMPLETEDNCT00003887·PHASE2·Fred Hutchinson Cancer Center
peripheral blood lymphocyte therapy
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
COMPLETEDNCT00003572·PHASE2·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·20 enrolled
peripheral blood lymphocyte therapymycophenolate mofetiltacrolimusallogeneic bone marrow transplantationradiation therapy
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
COMPLETEDNCT00049465·NA·Fred Hutchinson Cancer Center
fatigue assessment and managementmanagement of therapy complicationspsychosocial assessment and care
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
COMPLETEDNCT00019513·PHASE1·National Institutes of Health Clinical Center (CC)·108 enrolled
fluorouracilgemcitabine hydrochlorideleucovorin calcium
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
COMPLETEDNCT00003451·PHASE1·National Cancer Institute (NCI)·40 enrolled
recombinant interferon alfarecombinant interleukin-12
Treatment for Chronic Pain in Patients With Advanced Cancer
COMPLETEDNCT00003687·PHASE3·NCIC Clinical Trials Group·87 enrolled
dextromethorphan hydrobromidemorphine sulfate
UCN-01 in Treating Patients With Advanced Cancer
COMPLETEDNCT00003289·PHASE1·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
7-hydroxystaurosporine
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
COMPLETEDNCT00003368·PHASE1·National Cancer Institute (NCI)
irinotecan hydrochloride
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
COMPLETEDNCT00003541·PHASE1 / PHASE2·Memorial Sloan Kettering Cancer Center·24 enrolled
filgrastimCHOP regimencarboplatincyclophosphamidedoxorubicin hydrochloride+6 more
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00003661·PHASE2·Roswell Park Cancer Institute·3 enrolled
anti-thymocyte globulinbusulfancyclosporinemelphalanmethylprednisolone+2 more
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
WITHDRAWNNCT00004039·PHASE2·Hoag Memorial Hospital Presbyterian
recombinant interferon alfarituximabcyclophosphamidedoxorubicin hydrochlorideprednisone+1 more
Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
COMPLETEDNCT00003311·PHASE2·M.D. Anderson Cancer Center·19 enrolled
filgrastimcyclophosphamidecytarabinedexamethasonedoxorubicin hydrochloride+2 more
Bryostatin and Vincristine in B-Cell Malignancies
COMPLETEDNCT00003166·PHASE1·National Cancer Institute (NCI)·18 enrolled
bryostatin 1vincristine sulfatelaboratory biomarker analysis
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
UNKNOWNNCT00008307·PHASE2·Herbert Irving Comprehensive Cancer Center·52 enrolled
anti-thymocyte globulincyclosporinefludarabine phosphatemelphalanmethylprednisolone+4 more
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00003962·PHASE1·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
aldesleukin